Patent ID: 8367709
Filing Date: 2013-02-05
Classification: A61P,C07C,C07D

Abstract:
1. A compound of Formula (Ib) or (IIb): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein: L L M is —(CH R R R alternately, when two R R R R R R R alternatively, R R alternatively, R R R R alternately, when two R R R R R R R R R R n, at each occurrence, is selected from the group consisting of 0, 1, 2, 3, and 4; p, at each occurrence, is selected from the group consisting of 0, 1, and 2; and r, at each occurrence, is selected from the group consisting of 0, 1, 2, 3, and 4.